TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
BNGO Stock 12 Month Forecast
Average Price Target
$7.50
▲(362.96% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for BioNano Genomics in the last 3 months. The average price target is $7.50 with a high forecast of $8.00 and a low forecast of $7.00. The average price target represents a 362.96% change from the last price of $1.62.
trades and holding each position for 1 Month would result in 80.00% of your transactions generating a profit, with an average return of +9.46% per trade.
trades and holding each position for 3 Months would result in 80.00% of your transactions generating a profit, with an average return of +10.76% per trade.
Copying Cira Diagnissa 's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +10.76% per trade.
trades and holding each position for 2 Years would result in 80.00% of your transactions generating a profit, with an average return of +10.76% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
BNGO Analyst Recommendation Trends
Rating
May 25
Jun 25
Aug 25
Sep 25
Nov 25
Strong Buy
2
2
4
3
5
Buy
0
0
0
0
0
Hold
15
11
10
8
7
Sell
3
1
0
0
2
Strong Sell
0
0
0
0
0
total
20
14
14
11
14
In the current month, BNGO has received 5Buy Ratings, 7Hold Ratings, and 2Sell Ratings. BNGO average Analyst price target in the past 3 months is 7.50.
Each month's total comprises the sum of three months' worth of ratings.
BNGO Financial Forecast
BNGO Earnings Forecast
Next quarter’s earnings estimate for BNGO is -$1.36 with a range of -$1.90 to -$0.82. The previous quarter’s EPS was -$2.04. BNGO beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year BNGO has Performed in-line its overall industry.
Next quarter’s earnings estimate for BNGO is -$1.36 with a range of -$1.90 to -$0.82. The previous quarter’s EPS was -$2.04. BNGO beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year BNGO has Performed in-line its overall industry.
BNGO Sales Forecast
Next quarter’s sales forecast for BNGO is $7.93M with a range of $7.70M to $8.16M. The previous quarter’s sales results were $7.37M. BNGO beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year BNGO has Performed in-line its overall industry.
Next quarter’s sales forecast for BNGO is $7.93M with a range of $7.70M to $8.16M. The previous quarter’s sales results were $7.37M. BNGO beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year BNGO has Performed in-line its overall industry.
BNGO Stock Forecast FAQ
What is BNGO’s average 12-month price target, according to analysts?
Based on analyst ratings, Bionano Genomics’s 12-month average price target is 7.50.
What is BNGO’s upside potential, based on the analysts’ average price target?
Bionano Genomics has 362.96% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BNGO a Buy, Sell or Hold?
Bionano Genomics has a consensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Bionano Genomics’s price target?
The average price target for Bionano Genomics is 7.50. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $8.00 ,the lowest forecast is $7.00. The average price target represents 362.96% Increase from the current price of $1.62.
What do analysts say about Bionano Genomics?
Bionano Genomics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of BNGO?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.